methotrexate has been researched along with Hypopigmentation in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 3 (42.86) | 2.80 |
Authors | Studies |
---|---|
Lomonosov, K; Tavitova, A; Valle, Y | 1 |
Andreu, N; Boniface, K; Guyon, M; Merhi, R; Seneschal, J | 1 |
Speeckaert, R; van Geel, N | 1 |
Abdelmaksoud, A | 1 |
Boniface, K; Seneschal, J | 1 |
García-Romero, MT; Laxer, R; Pope, E; Taylor, G | 1 |
Haverstock, C; Jorizzo, JL; Sangüeza, OP; Walsh, SN | 1 |
2 review(s) available for methotrexate and Hypopigmentation
Article | Year |
---|---|
The real-life efficacy of methotrexate in vitiligo: A retrospective study and literature review.
Topics: Humans; Hypopigmentation; Methotrexate; Retrospective Studies; Treatment Outcome; Vitiligo | 2023 |
Vitiligo as a skin memory disease: The need for early intervention with immunomodulating agents and a maintenance therapy to target resident memory T cells.
Topics: Adult; Cell Differentiation; Cell Movement; Cell Proliferation; Female; Humans; Hypopigmentation; Immunologic Factors; Immunologic Memory; Immunomodulation; Male; Melanocytes; Methotrexate; Middle Aged; Oxidative Stress; Skin; Skin Pigmentation; T-Lymphocytes; Translational Research, Biomedical; Ultraviolet Rays; Vitiligo | 2019 |
5 other study(ies) available for methotrexate and Hypopigmentation
Article | Year |
---|---|
Using methotrexate in the treatment of advanced vitiligo.
Topics: Humans; Hypopigmentation; Methotrexate; Skin; Vitiligo | 2023 |
Efficacy and safety of the combination of steroid pulse therapy with methotrexate for vitiligo: A pilot retrospective case series.
Topics: Glucocorticoids; Humans; Hypopigmentation; Methotrexate; Retrospective Studies; Steroids; Treatment Outcome; Vitiligo | 2023 |
Methotrexate for treatment of vitiligo.
Topics: Humans; Hypopigmentation; Methotrexate; Vitiligo | 2017 |
Hypopigmented micropapules in apparently quiescent morphea lesions: a manifestation of disease activity.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Diagnosis, Differential; Disease Progression; Drug Therapy, Combination; Female; Folic Acid; Humans; Hypopigmentation; Immunosuppressive Agents; Male; Methotrexate; Methylprednisolone; Mycophenolic Acid; Scleroderma, Localized; Vitamin B Complex | 2013 |
A linear orofacial macule.
Topics: Administration, Oral; Adolescent; Biopsy, Needle; Drug Therapy, Combination; Follow-Up Studies; Humans; Hypopigmentation; Immunohistochemistry; Lichen Sclerosus et Atrophicus; Lip; Male; Methotrexate; Mouth Mucosa; Prednisone | 2008 |